EGFR and gastric cancer: Particularly, epidermal growth factor receptor family (ErbB) members [7–11], vascular endothelial growth factor receptor family (VEGFR) members [12–14] and PI3K/Akt/mTOR pathway components [15, 16] were found to be involved in the molecular pathogenesis of gastric cancer.